首页> 外文期刊>Journal of Physics: Conference Series >DNA methylation of the progesterone receptor B (PR-B) gene promoter in human eutopic endometrium, ectopic peritoneum, and ovarian endometriosis
【24h】

DNA methylation of the progesterone receptor B (PR-B) gene promoter in human eutopic endometrium, ectopic peritoneum, and ovarian endometriosis

机译:孕酮受体B(PR-B)基因启动子的DNA甲基化,在人抑制子宫内膜,异位腹膜和卵巢子宫内膜异位症中

获取原文
           

摘要

Endometriosis, a chronic inflammatory disorder, is characterized by the presence of hormone-responsive, endometrial-like tissue outside of the uterine inner wall, such as in the peritoneum and ovaries. Progesterone (P) resistance, due to altered expression of progesterone receptor (PR), is known as a disruptive condition in response to P in eutopic endometrial tissue. Gene promoter DNA methylation, a gene silencing mechanism, has been associated with the etiology of endometriosis. The aim of this cross sectional study was to assess the DNA methylation status of the PR-B promoter in various tissues (eutopic endometrium, ectopic peritoneal, and ovarian lesions) from endometriosis patient. This study involved 20 samples for each tissue type (eutopic endometrium, peritoneal, and ovarian lesion from women with endometriosis), as compared with 20 eutopic microcurettage samplings of normal endometrial tissue. DNA was isolated from each sample and subjected to bisulfite conversion. The DNA methylation level of the PR-B gene promoter was analyzed by the methylation-specific PCR (MSP) method. Band intensities in agarose gels were measured with ImageJ software. The ratio of the band intensity of samples to that of the positive control was considered as the DNA methylation level. The Mann–Whitney U test and Wilcoxon test were conducted, and P-values were considered significant at 0.05. There were significant differences in the methylation levels of the PR-B gene promoters in ectopic peritoneal endometrial tissue (72.40% methylated), ovarian tissue (85% methylated), and eutopic endometrial tissue (72.21% methylated), as compared to normal endometrium (P = 0.000). Moreover, there were no significant differences in methylation levels of the endometriosis samples, i.e., peritoneal vs. eutopic endometrial tissue, peritoneal vs. ovarian endometrial tissue, and ovarian vs. eutopic endometrial tissue (P = 0.636, 0.241, and 0.441, respectively). Hypermethylation of the PR-B gene promoter could cause P resistance in different types of endometriosis lesions and might be a potential biomarker for diagnosis of endometriosis.
机译:子宫内膜异位症,一种慢性炎症性疾病,其特征在于在子宫内壁外面的激素响应,子宫内膜状组织的存在,例如在腹膜和卵巢中。孕酮(P)抗性,由于孕酮受体(PR)的表达改变,被称为响应于P中的P中的破坏性条件。基因启动子DNA甲基化,基因沉默机制,与子宫内膜异位症的病因有关。该横截面研究的目的是评估来自子宫内膜异位症患者的各种组织(抑外症,异位腹膜和卵巢病变)中PR-B启动子的DNA甲基化状态。该研究涉及每个组织类型的20个样品(具有子宫内膜异位症的妇女的每个组织型(腹腔内膜,腹膜和卵巢病变),与正常子宫内膜组织的20个突出性微循环采样相比。从每个样品中分离DNA并进行亚硫酸氢盐转化。通过甲基化特异性PCR(MSP)方法分析PR-B基因启动子的DNA甲基化水平。用imagej软件测量琼脂糖凝胶中的带强度。样品的带强度与阳性对照的比率被认为是DNA甲基化水平。进行了Mann-Whitney U测试和Wilcoxon测试,并且P值被认为是显着的<0.05。与正常子宫内膜相比,卵巢组织(72.40%甲基化),卵巢组织(85%甲基化),卵巢组织(甲基化)(72.21%甲基化)中,PR-B基因启动子的甲基化水平存在显着差异p = 0.000)。此外,子宫内膜异位症样品的甲基化水平没有显着差异,即腹膜与卵巢子宫内膜组织,腹膜与卵巢子宫内膜组织,卵巢与卵巢子宫内膜组织(P = 0.636,0.241和0.441) 。 PR-B基因启动子的高甲基化可能导致不同类型的子宫内膜异位病变中的P抗性,并且可能是用于诊断子宫内膜异位症的潜在生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号